The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity

Table 5

Logistic regression model for cardiotoxicity predictors.

	value
LVEF T3 (%)	0.577
GLS T3 (%)	0.08
GLS variation T3 (%)	0.008
Cumulative epirubicin dose (mg/m^2)	0.280
Cancer stage (early vs. metastatic)	0.803
Age	0.483

T3: at three months. T12: at 12 months. GLS: global longitudinal strain. LVEF: left ventricular ejection fraction.